Anindya Sen

Anindya Sen serves as the Vice President and Head of Pre-Clinical Development at AIRNA since 2024, following a role as Head of Preclinical Research and Development at Prevail Therapeutics, where Anindya held various leadership positions from 2019 to 2024. Prior experience includes significant roles at Eli Lilly and Company, Biogen, Harvard Medical School, and Columbia University, specializing in pre-clinical drug development, particularly in neurodegeneration and gene therapy. Anindya's academic credentials include a Ph.D. in Molecular Biology from the Tata Institute of Fundamental Research and a Bachelor's degree in Human Physiology from Harvard Medical School, complemented by a Master's degree in Biotechnology from Banaras Hindu University.